CorrespondenceExhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis
References (5)
- et al.
Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension
Lancet
(1998) - et al.
Intravenous nitrite vasodilators and exhaled nitric oxide
Lancet
(1997)
There are more references available in the full text version of this article.
Cited by (5)
Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: Recipient-related risk factors and markers
2005, Journal of Heart and Lung TransplantationExhaled nitric oxide as a marker of lung injury in coronary artery bypass surgery (multiple letters) [1]
2003, British Journal of AnaesthesiaA new method of iloprost administration without a peristaltic pump
2000, Current Therapeutic Research - Clinical and ExperimentalPlasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with Systemic Sclerosis
2009, Journal of Biological Regulators and Homeostatic AgentsExhaled nitric oxide in human lung ischemia-reperfusion
2002, Disease Markers in Exhaled Breath
Copyright © 1998 Elsevier Ltd. All rights reserved.